Disruptive Affektregulations- störung: eine umstrittene neue Diagnose im DSM-5
Disruptive Mood Dysregulation Disorder: a controversial new diagnostic entity in the DSM-5
Abstract
Zusammenfassung. Die Disruptive Affektregulationsstörung wurde in die 5. Auflage des DSM erstmals als Störungsbild aufgenommen. Den Anlass, eine eigenständige diagnostische Kategorie im Kapitel „Depressive Störungen“ für einen Verhaltensphänotyp aus chronischer, nichtepisodischer Reizbarkeit und häufigen plötzlichen Wutanfällen zu entwickeln, gab die transatlantische Kontroverse um das klinische Bild und die Prävalenz früh beginnender bipolarer Störungen. Die vorliegende Arbeit stellt erste vorliegende Arbeiten dar, die auf die neuen Kriterien zurückgreifen. Während die Abgrenzbarkeit der Disruptiven Affektregulationsstörung in Symptomatik und Verlauf von bipolaren Störungen gut gelingt, finden sich Hinweise auf starke Überlappungen mit oppositionell-gereizten Symptombildern. Für die anstehende Revision der ICD sollte daher diskutiert werden, keine neue Diagnose, sondern eher eine Zusatzcodierung einzuführen, die kennzeichnet, ob eine oppositionelle Störung auch reizbar-wütendes Verhalten umfasst. Unabhängig von der nosologischen Einordnung besteht die Herausforderung, den Verhaltensphänotyp hinsichtlich Ätiologie, Entwicklungspsychopathologie und Prognose besser zu verstehen und hilfreiche Behandlungsmöglichkeiten zu entwickeln.
Abstract. The Disruptive Mood Dysregulation Disorder (DMDD) was included for the first time in the 5th Revision of the DSM. A transatlantic controversy surrounding the clinical picture and prevalence of early-onset bipolar disorder gave the occasion to develop a new diagnostic category in the chapter “Depressive Disorders” capturing a behavioral phenotype of non-episodic, chronic irritability and frequent temper tantrums. The present paper reviews the first available studies applying the new criteria. While DMDD can be clearly distinguished from bipolar disorder, preliminary evidence suggests a strong overlap with oppositional-defiant disorders (ODD). For the upcoming revision of the ICD it should be discussed to introduce a specifier indicating whether or not the presentation of ODD includes chronic irritability and anger, rather than establishing a new diagnosis. Regardless of the nosological categorization of the described behavioral phenotype main challenges represent a better understanding with regard to its etiology, developmental psychopathology and prognosis and the development of beneficial treatment options.
Literatur
2013). Diagnostic and Statistical Manual of Mental Disorders Fifth Edition: DSM 5. Washington, DC, London: American Psychiatric Publishing.
. (2015). Zehn Jahre Erfahrung mit der Dialektisch-Behavioralen Therapie für Adoleszente (DBT-A) unter stationären Bedingungen – die Station Wellenreiter. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 43(5), 301–313.
(2012). Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study. Journal of Clinical Psychiatry, 73(10), 1342–1350.
, (2009). Practitioner review: the assessment of bipolar disorder in children and adolescents. Journal of Child Psychology and Psychiatry, 50(3), 203–215.
(2005). Clinical correlates of bipolar disorder in a large, referred sample of children and adolescents. Journal of Psychiatric Research, 39, 611–622.
, (2007). Increased rates of bipolar disorder diagnoses among U. S. child, adolescent, and adult inpatients, 1996–2004. Biological Psychiatry, 62, 107–114.
(2007). Parental diagnoses in youth with narrow phenotype bipolar disorder or severe mood dysregulation. American Journal of Psychiatry, 164, 1238–1241.
, (2006). Prevalence, clinical correlates, and longitudinal course of severe mood dys-regulation in children. Biological Psychiatry, 60, 991–997.
, (1998). Mania and ADHD: comorbidity or confusion. Journal of Affective Disorders, 51, 177–187.
(2010). Liquid risperidone in the treatment of rages in psychiatrically hospitalized children with possible bipolar disorder. Bipolar Disorders, 12(2), 205–212.
(2013). Prevalence, comorbidity and correlates of DSM-5 proposed disruptive mood dysregulation disorder. American Journal of Psychiatry, 170(2), 173–179.
(2009). Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation. Journal of Child and Adolescent Psychopharmacology, 19(1), 61–73.
, (2014). DSM-5 disruptive mood dysregulation disorder: correlates and predictors in young children. Psychological Medicine, 44(11), 2339–2350.
, (2016). Disruptive mood dysregulation disorder at the age of 6 years and clinical and functional outcomes 3 years later. Psychological Medicine, 46(5), 1103–1114.
(2015). Diagnostische Kriterien DSM-5. Göttingen: Hogrefe.
, ) (2015). Treatment of children with attention-deficit/hyperactivity disorder (ADHD) and irritability: results from the multimodal treatment study of children with ADHD (MTA). Journal of the American Academy of Child and Adolescent Psychiatry, 54(1), 62–70.
(2013). Normal. Gegen die Inflation psychiatrischer Diagnosen. Köln: Dumont.
(2016). Verordnungshäufigkeiten von Psychopharmaka bei Kindern und Jugendlichen mit psychischen Erkrankungen in Deutschland. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie (im Druck).
(2002). DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. Journal of Child and Adolescent Psychopharmacology, 12, 11–25.
, (2015). Efficacy of an individualized social competence training for children with oppositional defiant disorders/conduct disorders. Psychotherapy Research (online). doi: 10.1080/10503307.2015.1094587.
, (2010). Therapieprogramm für Kinder mit aggressivem Verhalten (THAV). Göttingen: Hogrefe.
(2010). Früh beginnende bipolare Störungen, ADHS oder Störung der Affektregulation? Kindheit und Entwicklung, 19, 192–201.
(2009). Früh beginnende bipolare Störungen – unterdiagnostiziert oder überbewertet. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 37(3), 159–161.
(2008). CBCL-pediatric bipolar disorder phenotype: severe ADHD or bipolar disorder? Journal of Neural Transmission, 115, 155–161.
(2011). The Child Behavior Checklist-Dysregulation Profile predicts substance use, suicidality, and functional impairment: a longitudinal analysis. Journal of Child Psychology and Psychiatry, 52(2), 139–147.
(2010). Severe affective and behavioral dysregulation in youth is associated with increased serum TSH. Journal of Affective Disorders, 121(1–2), 184–188.
(2010). Bipolar disorder in children and adolescents in Germany: national trends in the rates of inpatients, 2000–2007. Bipolar Disorders, 12, 155–163.
(2016). Störungen der Affektregulation. Leitfaden Kinder- und Jugendpsychotherapie, Bd. 22. Göttingen: Hogrefe.
(2013). Severe affective and behavioral dysregulation in youths is associated with a pro-inflammatory state. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 41(6), 393–400.
, (2014). DSM-5 – die Revisionen und ihre Implikationen für die Kinder- und Jugendpsychiatrie. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 42(2), 81–83.
(2011). Severe affective and behavioural dysregulation is associated with significant psychosocial adversity and impairment. Journal of Child Psychology and Psychiatry, 52(6), 686–695.
, (2011). An open-label trial of risperidone in children and adolescents with severe mood dysregulation. Journal of Child and Adolescent Psychopharmacology, 21, 237–243.
, (2003). Defining clinical phenotypes of juvenile mania. American Journal of Psychiatry, 160, 430–437.
(2015). An empirically based alternative to DSM-5›s disruptive mood dysregulation disorder for ICD-11. World Psychiatry, 14(1), 30–33.
, (2004). The Coping Power Program for preadolescent aggressive boys and their parents: outcome effects at the 1 Year folllow-up. Journal of Consulting and Clinical Psychology, 72(4), 571–578.
(2009). Long-term outcomes of youth who manifested the CBCL-pediatric bipolar disorder phenotype during childhood and/or adolescence. Journal of Affective Disorders, 113, 227–235.
, (2007). National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of General Psychiatry, 64, 1032–1039.
(2009). Adult outcomes of youth irritability: a 20-year prospective community-based study. American Journal of Psychiatry, 166(9), 1048–1054.
(2009). Longitudinal outcome of youth oppositionality: irritable, headstrong, and hurtful behaviors have distinctive predictions. Journal of the American Academy of Child and Adolescent Psychiatry, 48(4), 404–412.
(2008). The Efficacy and Tolerability of Methylphenidate and Behavior Modification in Children with Attention-Deficit/Hyperactivity Disorder and Severe Mood Dysregulation. Journal of Child and Adolescent Psychopharmacology, 18(6), 573–588. http://doi.org/10.1089/cap.2008.065.
(2013). A novel group therapy for children with ADHD and severe mood dysregulation. Journal of Attention Disorders, 17(6), 527–541.
, (2013). Developmental continuity of oppositional defiant disorder subdimensions at ages 8, 10, and 13 years and their distinct psychiatric outcomes at age 16 years. Journal of the American Academy of Child and Adolescent Psychiatry, 52(9), 961–969.
(